Universe Pharmaceuticals (UPC) Accounts Payables (2021 - 2025)
Universe Pharmaceuticals (UPC) has disclosed Accounts Payables for 5 consecutive years, with $262.6 million as the latest value for Q3 2025.
- Quarterly Accounts Payables fell 25.57% to $262.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $262.6 million through Sep 2025, down 25.57% year-over-year, with the annual reading at $262.6 million for FY2025, 25.57% down from the prior year.
- Accounts Payables hit $262.6 million in Q3 2025 for Universe Pharmaceuticals, down from $352.9 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $352.9 million in Q3 2024 to a low of $3.1 million in Q3 2022.
- Historically, Accounts Payables has averaged $125.7 million across 5 years, with a median of $5.3 million in 2021.
- Biggest five-year swings in Accounts Payables: tumbled 42.09% in 2022 and later soared 7595.36% in 2024.
- Year by year, Accounts Payables stood at $5.3 million in 2021, then crashed by 42.09% to $3.1 million in 2022, then skyrocketed by 49.1% to $4.6 million in 2023, then skyrocketed by 7595.36% to $352.9 million in 2024, then fell by 25.57% to $262.6 million in 2025.
- Business Quant data shows Accounts Payables for UPC at $262.6 million in Q3 2025, $352.9 million in Q3 2024, and $4.6 million in Q3 2023.